Wegovy

Indicated For

obesity, chronic weight management, overweight with weight-related conditions

About This Medication

# Wegovy Patient Assistance: Savings Options and Support Programs ## Important Note About Wegovy Assistance While Novo Nordisk, the manufacturer of Wegovy (semaglutide), offers several cost-reduction programs, it is important to understand that **Wegovy is not currently covered by the Novo Nordisk Patient Assistance Program (PAP)**. However, multiple savings options are available to help make Wegovy more affordable. ## About Wegovy (Semaglutide) Wegovy is an FDA-approved prescription medication containing semaglutide, a GLP-1 receptor agonist used for chronic weight management. It is prescribed to: - Adults with obesity or overweight individuals who have weight-related medical conditions - Children 12 years and older with obesity - Adults with known heart disease and obesity or overweight to reduce the risk of major cardiovascular events Wegovy is available as a weekly injection (0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg) or as oral tablets (1.5 mg, 4 mg, 9 mg, or 25 mg). The medication works best when combined with a reduced-calorie diet and increased physical activity. ## Available Savings Programs ### 1. Wegovy Savings Card (Commercial Insurance) If you have commercial insurance (not Medicare or Medicaid), you may qualify for the Wegovy savings card: - **Copay assistance**: Pay as little as $25 per month, with maximum savings of $100 per month for a 1-month supply - **Multi-month supplies**: Save up to $200 for 2-month supplies or $300 for 3-month supplies - **Eligibility**: Must have a valid commercial insurance plan and a prescription for an FDA-approved indication - **Age requirement**: Must be at least 18 years old and a U.S. resident or Puerto Rico resident ### 2. Self-Pay Pricing If you do not have insurance or prefer to pay out-of-pocket: **Injectable Wegovy:** - 0.25 mg and 0.5 mg: $199 per month (limited to 2 monthly fills) - 1.7 mg and 2.4 mg: $349 per month **Tablet Wegovy:** - 1.5 mg and 4 mg: $149 per month (4 mg offer available until August 31, 2026; $199/month thereafter) - 9 mg and 25 mg: $299 per month ### 3. NovoCare Pharmacy Patients without insurance coverage can fill Wegovy prescriptions through NovoCare Pharmacy, which offers access to the medication at negotiated rates. ### 4. Additional Financial Assistance The **PAN Foundation** offers grants up to $1,000 for treatment of obesity, including FDA-approved GLP-1 medications like Wegovy, for eligible individuals. ## Insurance Requirements and Eligibility ### Who Qualifies for Savings Programs - **Commercial insurance holders**: Eligible for the Wegovy savings card with copay assistance - **Uninsured patients**: Can access self-pay pricing or NovoCare Pharmacy options - **Medicare/Medicaid beneficiaries**: Generally excluded from manufacturer savings programs; check with your plan for coverage options - **Government beneficiaries**: Excluded from the Wegovy savings card program **Important**: The Novo Nordisk Patient Assistance Program does not currently cover Wegovy, even for low-income uninsured patients. However, patients with Wegovy prescriptions can explore alternative assistance through programs like the PAN Foundation or state-based pharmaceutical assistance programs. ## Step-by-Step Application Process ### For Savings Card (Commercial Insurance) 1. **Verify your coverage**: Visit WegovyCoverage.com to check your insurance coverage in approximately 90 seconds 2. **Obtain a prescription**: Get a valid Wegovy prescription from your healthcare provider for an FDA-approved indication 3. **Enroll in the savings card**: Register at the Novo Nordisk website or through your pharmacy 4. **Present at pharmacy**: Provide your savings card information when filling your prescription 5. **Pay copay**: Pay as little as $25 per month (up to the maximum savings limit) ### For Self-Pay or Uninsured Patients 1. **Obtain a prescription**: Get a valid Wegovy prescription from your healthcare provider 2. **Choose your option**: - Fill through a standard pharmacy at self-pay rates, or - Fill through NovoCare Pharmacy for potentially lower costs 3. **Pay at pharmacy**: Pay the self-pay price at the time of filling ### For PAN Foundation Assistance 1. **Check eligibility**: Visit panfoundation.org to verify you meet income and other requirements 2. **Complete application**: Submit the required documentation 3. **Receive grant**: If approved, receive up to $1,000 toward obesity treatment costs ## Timeline and Delivery ### Processing and Approval - **Savings card enrollment**: Typically immediate upon registration - **NovoCare Pharmacy**: Medication usually ships directly to your home or physician's office - **PAN Foundation grants**: Approval timelines vary; check the foundation's website for specific timeframes ### Prescription Refills - **Savings card**: Redeemable for each new prescription fill; no reauthorization typically required - **Self-pay**: Available for each monthly refill at the stated price - **Copay reimbursement**: If you paid full price before enrolling, you can submit claims within 180 days for reimbursement (allow 6-8 weeks for processing) ## What to Do If Your Application Is Denied If you are denied assistance through one program: 1. **Explore alternative programs**: Try other savings options (e.g., if denied for the savings card, explore self-pay pricing or PAN Foundation assistance) 2. **Review eligibility**: Verify you meet all requirements; contact the program administrator if you have questions 3. **Appeal if applicable**: Some programs allow appeals; check program terms 4. **Consult your healthcare provider**: Your doctor may have information about additional resources or alternative medications 5. **Contact patient advocacy organizations**: Organizations focused on obesity treatment may offer additional guidance ## Important Considerations ### Medicare and Medicaid Medicare and Medicaid beneficiaries are generally excluded from manufacturer savings programs. However: - Check with your specific Medicare or Medicaid plan, as coverage policies vary - Some state Medicaid programs may cover Wegovy; contact your state program directly - Discuss alternative options with your healthcare provider ### Reauthorization Most Wegovy savings programs do not require annual reauthorization. However: - Maintain your enrollment status by continuing to use the program - Notify the program if your insurance changes - Check program terms for any updates to eligibility requirements ## Disclaimer This guide provides general information about Wegovy assistance programs as of March 2026. Program details, pricing, and eligibility requirements are subject to change at any time. Novo Nordisk reserves the right to modify or cancel these programs. Always verify current program terms and eligibility at official websites (WegovyCoverage.com, WegovyTerms.com, or NovoCare.com) or by contacting your healthcare provider or pharmacist. This information is not medical advice; consult your healthcare provider about whether Wegovy is appropriate for you and to discuss all available treatment options.

Program information last verified: March 30, 2026